© 2020 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Trial compares NMSC destructive techniques
October 21, 2020
A recent study showed that curettage and cryotherapy, and electrodesiccation and curettage are two techniques that have comparable cure rates. The study’s findings highlight the efficacy and reliability of these treatment approaches for minimally invasive cutaneous carcinomas.
Dupilumab provides option for severe AD in younger children
October 21, 2020
In a recent phase 3 trial, dupilumab (Dupixent, Sanofi and Regeneron) demonstrated positive results in itch reduction, skin clearance and quality-of-life. Indicating the biologic as a viable treatment option for severe atopic dermatitis in younger children.
The Mainstream Patient: October 20
October 20, 2020
This week’s edition of The Mainstream Patient features stories about postpartum hair loss, vitamin C benefits, witch hazel, fraxel laser treatments, isotretinoin’s effect on both the skin and mind, oily skin myths, plus more.
Older adults underrepresented in atopic dermatitis research
October 20, 2020
A recent review reveals older adults are underrepresented in trials investigating systemic immunomodulators as a treatment for atopic dermatitis.
Negotiating better managed care contracts
October 20, 2020
Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
What’s new on Dermatology Times: October 19-23
October 19, 2020
A glimpse at what to expect from Dermatology Times this week.
POLL: Have you ever experienced symptoms of imposter syndrome?
October 19, 2020
Selling your practice: The due diligence, legal documentation and final negotiation phases
October 19, 2020
Todd Petersen, CEO of VitalSkin Dermatology, covers the ins and outs of the due diligence, legal documentation and final negotiation stages of selling a practice.
Weekly Roundup: October 12-16
October 16, 2020
ICYMI, some of the content featured this week includes new 730 nm picosecond laser for benign pigmented lesions, managing patient volumes during the COVID-19 pandemic, tips on how to build your brand as a physician, plus more.
Phenotype-based approach advances management
October 16, 2020
The 21-member global ROSacea Consensus panel developed updated recommendations for rosacea, diagnosis, classification and management to support and promote transition to a phenotype approach in rosacea.
Misinformation delays rosacea diagnosis in skin of color patients
October 16, 2020
The idea that rosacea is uncommon in darker skinned individuals may be due to under-recognition. Careful clinical examination, a thorough history and biopsy in some cases are needed for accurate diagnosis and differentiating rosacea from diseases that may be more common.
The retinoid revolution
October 15, 2020
Zoe Diana Draelos, M.D., shares why retinoids can be found in many anti-aging formulations and how to reduce irritation from this potent antioxidant.
Managing pandemic patient volumes
October 15, 2020
Since the start of the pandemic, dermatologists have seen an average 50% drop in patient volume. While teledermatology has offered a channel for non-urgent patients and patient visits are rebounding, overall patient volumes are still significantly lower than 2019.
Tips for building your brand
October 15, 2020
In the final installment of this video series, Paige Velasquez Budde, CEO of Zilker Media, provides some useful tips for jump starting your brand as a physician.
I warned my patient – was it enough?
October 14, 2020
In this month’s Legal Eagle article, David J. Goldberg, M.D., J.D., discusses the different professional standards of disclosure that a physician must fulfill when treating patients.